Fabrice Bailly - Search Results

Year	Number of Results
2003	2
2004	2
2005	2
2006	1
2007	2
2008	5
2010	3
2011	2
2012	2
2013	3
2014	2
2015	1
2016	2
2017	3
2018	3
2019	1
2021	3
2022	1

1

Targeting Transcriptional Enhanced Associate Domains (TEADs).

Gibault F, Sturbaut M, Bailly F, Melnyk P, Cotelle P. Gibault F, et al. Among authors: bailly f. J Med Chem. 2018 Jun 28;61(12):5057-5072. doi: 10.1021/acs.jmedchem.7b00879. Epub 2017 Dec 28. J Med Chem. 2018. PMID: 29251924 Review.

2

Non-Photoinduced Biological Properties of Verteporfin.

Gibault F, Corvaisier M, Bailly F, Huet G, Melnyk P, Cotelle P. Gibault F, et al. Among authors: bailly f. Curr Med Chem. 2016;23(11):1171-84. doi: 10.2174/0929867323666160316125048. Curr Med Chem. 2016. PMID: 26980565 Review.

3

The preclinical discovery and development of dolutegravir for the treatment of HIV.

Bailly F, Cotelle P. Bailly F, et al. Expert Opin Drug Discov. 2015;10(11):1243-53. doi: 10.1517/17460441.2015.1064896. Epub 2015 Sep 7. Expert Opin Drug Discov. 2015. PMID: 26517818 Review.

4

Design, Synthesis and Evaluation of a Series of 1,5-Diaryl-1,2,3-triazole-4-carbohydrazones as Inhibitors of the YAP-TAZ/TEAD Complex.

Gibault F, Sturbaut M, Coevoet M, Pugnière M, Burtscher A, Allemand F, Melnyk P, Hong W, Rubin BP, Pobbati AV, Guichou JF, Cotelle P, Bailly F. Gibault F, et al. Among authors: bailly f. ChemMedChem. 2021 Sep 16;16(18):2823-2844. doi: 10.1002/cmdc.202100153. Epub 2021 Jul 1. ChemMedChem. 2021. PMID: 34032019

5

Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.

Sturbaut M, Bailly F, Coevoet M, Sileo P, Pugniere M, Liberelle M, Magnez R, Thuru X, Chartier-Harlin MC, Melnyk P, Gelin M, Allemand F, Guichou JF, Cotelle P. Sturbaut M, et al. Among authors: bailly f. Eur J Med Chem. 2021 Dec 15;226:113835. doi: 10.1016/j.ejmech.2021.113835. Epub 2021 Sep 6. Eur J Med Chem. 2021. PMID: 34509860

6

Anti-HIV activities of natural antioxidant caffeic acid derivatives: toward an antiviral supplementation diet.

Bailly F, Cotelle P. Bailly F, et al. Curr Med Chem. 2005;12(15):1811-8. doi: 10.2174/0929867054367239. Curr Med Chem. 2005. PMID: 16029149 Review.

7

The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target.

Rona G, Zeke A, Miwatani-Minter B, de Vries M, Kaur R, Schinlever A, Garcia SF, Goldberg HV, Wang H, Hinds TR, Bailly F, Zheng N, Cotelle P, Desmaële D, Landau NR, Dittmann M, Pagano M. Rona G, et al. Among authors: bailly f. Cell Death Differ. 2022 Feb;29(2):285-292. doi: 10.1038/s41418-021-00900-1. Epub 2021 Dec 3. Cell Death Differ. 2022. PMID: 34862481 Free PMC article.

8

Metal chelators for the inhibition of the lymphocytic choriomeningitis virus endonuclease domain.

Saez-Ayala M, Laban Yekwa E, Mondielli C, Roux L, Hernández S, Bailly F, Cotelle P, Rogolino D, Canard B, Ferron F, Alvarez K. Saez-Ayala M, et al. Among authors: bailly f. Antiviral Res. 2019 Feb;162:79-89. doi: 10.1016/j.antiviral.2018.12.008. Epub 2018 Dec 14. Antiviral Res. 2019. PMID: 30557576

9

Antioxidant properties of 3-hydroxycoumarin derivatives.

Bailly F, Maurin C, Teissier E, Vezin H, Cotelle P. Bailly F, et al. Bioorg Med Chem. 2004 Nov 1;12(21):5611-8. doi: 10.1016/j.bmc.2004.07.066. Bioorg Med Chem. 2004. PMID: 15465339

10

Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein⁻Protein Interface.

Gibault F, Coevoet M, Sturbaut M, Farce A, Renault N, Allemand F, Guichou JF, Drucbert AS, Foulon C, Magnez R, Thuru X, Corvaisier M, Huet G, Chavatte P, Melnyk P, Bailly F, Cotelle P. Gibault F, et al. Among authors: bailly f. Cancers (Basel). 2018 May 8;10(5):140. doi: 10.3390/cancers10050140. Cancers (Basel). 2018. PMID: 29738494 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results